Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luis Toro

Showing results (31-40 of 35) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 35 results.
Kidney International|February 4, 2018
Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injuryLuis Toro, Víctor Barrientos, Pablo León, et al.
American Heart Journal|August 17, 2004
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen, Kenneth W Mahaffey, Richard C Becker, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 30, 2022
Survival study and factors associated with mortality in Chilean patients on peritoneal dialysis infected with SARS-CoV-2Ana M Ortiz, Rodrigo A Sepúlveda, Rubén Torres, et al.
JAMA|July 9, 2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.
Kidney International Reports|July 25, 2022
Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis PatientsRubén Torres, Luis Toro, María Eugenia Sanhueza, et al.
Pageof 4

Showing results (31-40 of 35) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 35 results.
Kidney International|February 4, 2018
Erythropoietin induces bone marrow and plasma fibroblast growth factor 23 during acute kidney injuryLuis Toro, Víctor Barrientos, Pablo León, et al.
American Heart Journal|August 17, 2004
Coordinated series of studies to evaluate characteristics and mechanisms of acute coronary syndromes in high-risk patients randomly assigned to enoxaparin or unfractionated heparin: design and rationale of the SYNERGY LibraryJohn L Petersen, Kenneth W Mahaffey, Richard C Becker, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 30, 2022
Survival study and factors associated with mortality in Chilean patients on peritoneal dialysis infected with SARS-CoV-2Ana M Ortiz, Rodrigo A Sepúlveda, Rubén Torres, et al.
JAMA|July 9, 2004
Enoxaparin vs unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes managed with an intended early invasive strategy: primary results of the SYNERGY randomized trialJames J Ferguson, Robert M Califf, Elliott M Antman, et al.
Kidney International Reports|July 25, 2022
Clinical Efficacy of SARS-CoV-2 Vaccination in Hemodialysis PatientsRubén Torres, Luis Toro, María Eugenia Sanhueza, et al.
Pageof 4